Sanford Applied BiosciencesHematech Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Sanford Applied BiosciencesHematech General Information

Description

Developer of pharmaceutical products. The company produces fully human antibodies, both monoclonal and polyclonal, using gene engineering and transfer to produce new bio-pharmaceuticals that help fight disease.

Contact Information

Formerly Known As
Hematech
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 2301 East 60th Street North
  • Sioux Falls, SD 57104
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanford Applied BiosciencesHematech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sanford Applied BiosciencesHematech‘s full profile, request access.

Request a free trial

Sanford Applied BiosciencesHematech Executive Team (1)

Name Title Board Seat Contact Info
James Barton Chief Executive Officer & Co-Founder
To view Sanford Applied BiosciencesHematech’s complete executive team members history, request access »

Sanford Applied BiosciencesHematech Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sanford Applied BiosciencesHematech‘s full profile, request access.

Request a free trial